Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (381-390 of 548) with videos related to

Pageof 55
Sort By:
European Urology Oncology|June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer TreatmentUgo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
Urologic Oncology|June 20, 2021
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Alberto Martini, Daniele Raggi, et al.
Prostate Cancer and Prostatic Diseases|September 19, 2025
Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized studyAlessandro Uleri, Eric Potiron, Naoufel Miaadi, et al.
Arthritis Care & Research|July 24, 2020
Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic ArthritisHermine I Brunner, Chen Chen, Francesca Bovis, et al.
European Urology Oncology|May 3, 2022
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Chiara Lonati, Luigi Nocera, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2022
Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
Frontiers in Immunology|November 19, 2024
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer modelAlexis R Steinmetz, Morgan Pierce, Alberto Martini, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Clinical Genitourinary Cancer|February 2, 2022
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical NephroureterectomyAlberto Martini, Chiara Lonati, Francesco Montorsi, et al.
Minerva Urology and Nephrology|October 26, 2022
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaborationCarlo A Bravi, Elio Mazzone, Paolo Dell'oglio, et al.
Pageof 55

Showing results (381-390 of 548) with videos related to

Sort By:
Pageof 55
European Urology Oncology|June 22, 2025
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer TreatmentUgo Giovanni Falagario, Francesco Pellegrino, Lars Björnebo, et al.
Urologic Oncology|June 20, 2021
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Alberto Martini, Daniele Raggi, et al.
Prostate Cancer and Prostatic Diseases|September 19, 2025
Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized studyAlessandro Uleri, Eric Potiron, Naoufel Miaadi, et al.
Arthritis Care & Research|July 24, 2020
Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic ArthritisHermine I Brunner, Chen Chen, Francesca Bovis, et al.
European Urology Oncology|May 3, 2022
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Chiara Lonati, Luigi Nocera, et al.
Prostate Cancer and Prostatic Diseases|October 8, 2022
Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
Frontiers in Immunology|November 19, 2024
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer modelAlexis R Steinmetz, Morgan Pierce, Alberto Martini, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Clinical Genitourinary Cancer|February 2, 2022
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical NephroureterectomyAlberto Martini, Chiara Lonati, Francesco Montorsi, et al.
Minerva Urology and Nephrology|October 26, 2022
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaborationCarlo A Bravi, Elio Mazzone, Paolo Dell'oglio, et al.
Pageof 55